Trial Profile
Development of population pharmacokinetic-pharmacodynamic (PK-PD) models of mycophenolic acid for Bayesian dose individualization in pediatric kidney transplant patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Pharmacokinetics
- 18 Dec 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 14 Oct 2006 New trial record.